Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 1—January 2008

Research

Human Metapneumovirus Infections in Children

Terho Heikkinen*Comments to Author , Riikka Österback†, Ville Peltola*, Tuomas Jartti*, and Raija Vainionpää†
Author affiliations: *Turku University Hospital, Turku, Finland; †University of Turku, Turku, Finland;

Main Article

Table 4

Clinical characteristics and socioeconomic effects of human metapneumovirus (hMPV) infections in children, Finland, 2000–2001*

VariableAge group, y†
All children (n = 39)
1–2 (n = 18)3–4 (n = 15)5–9 (n = 6)
Signs and symptoms
Cough18 (100)15 (100)5 (83)38 (97)
Rhinitis17 (94)13 (87)5 (83)35 (90)
Fever >37.5°C13 (72)13 (87)2 (33)28 (72)
Vomiting1 (6)1 (7)02 (5)
Wheezing2 (11)1 (7)1 (17)4 (10)
Laryngitis1 (6)2 (13)03 (8)
Median duration of illness, d
9.5
8
7
8
Complications
Acute otitis media11 (61)4 (27)1 (17)16 (41)
Pneumonia1 (6)001 (3)
Antimicrobial drug treatment
11 (61)
3 (20)
1 (17)
15 (38)
Absenteeism
Child´s absence from daycare or school for >1 d10 (56)8 (53)3 (50)21 (54)
Mean duration of child’s absence, d‡3.72.93.03.3
Parental absence from work for >1 d9 (50)4 (27)2 (33)15 (38)
Mean duration of parental absence, d‡2.92.54.02.9

*Values are no. children (%) unless otherwise stated.
†Age at diagnosis of hMPV infection.
‡Calculated for children or parents who were absent for at least 1 d.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO